NPPA Revises Prices of 543 Anti-Cancer Medicine Brands, New Rates Effective November 9
The National Pharmaceutical Pricing Authority (NPPA) has announced revised maximum retail prices (MRPs) for 543 brands of anti-cancer medicines following…
Dr Reddy
Read More
Dr Reddy’s Launches Low-Cost Semaglutide Generic ‘Obeda’ in India’s Booming GLP-1 Market
Dr. Reddy’s Laboratories has entered the fast-growing GLP-1 therapy segment with the launch of its semaglutide generic, Obeda, for Type…